Vitamin C protects against oxidative stress brought on by free radicals
Xultophy 100/3.6 (active ingredients: insulin degludec and liraglutide) subcutaneous injection Initial FDA Approval: 2016 Side Effect Update Date: May 28, 2025 Medication Description: Treats type 2 diabetes Updated Side Effects/Safety Information: A new warning section on Severe Gastrointestinal Adverse Reactions. An additional new warning about the risk of serious kidney injury caused by dehydration due to gastrointestinal adverse effects like diarrhea and vomiting
Ingredients: CoQ10 (naturally fermented), L-Carnitine, buffered chelated magnesium, hypromellose (vegetarian capsule), silicon dioxide, magnesium stearate (vegetable source), microcrystalline cellulose
Sustained weight loss with combined LEAP2 and semaglutide treatment in mice
Murugadoss, K., Varma, G., Venkatakrishnan, A
Pharmacists Verdict For most people using an injectable GLP-1 medicine, supplements do not need to be scheduled around injection day
